- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Trial Phase
Trial Status
Paid Participation
Clear All
Trial Details
Key Eligibility Criteria
115 Participants Needed
Trial Details
Key Eligibility Criteria
280 Participants Needed
Trial Details
Key Eligibility Criteria
203 Participants Needed
Trial Details
Key Eligibility Criteria
174 Participants Needed
Trial Details
Key Eligibility Criteria
857 Participants Needed
Trial Details
Key Eligibility Criteria
500 Participants Needed
Trial Details
Key Eligibility Criteria
141 Participants Needed
Trial Details
Key Eligibility Criteria
67 Participants Needed
Trial Details
Key Eligibility Criteria
534 Participants Needed
Trial Details
Key Eligibility Criteria
1609 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
63 Participants Needed
Trial Details
Key Eligibility Criteria
17 Participants Needed
Trial Details
Key Eligibility Criteria
45 Participants Needed
Trial Details
Key Eligibility Criteria
70 Participants Needed
Trial Details
Key Eligibility Criteria
31 Participants Needed
Trial Details
Key Eligibility Criteria
62 Participants Needed
Trial Details
Key Eligibility Criteria
168 Participants Needed
Trial Details
Key Eligibility Criteria
104 Participants Needed
Trial Details
Key Eligibility Criteria
818 Participants Needed
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Trial Details
Key Eligibility Criteria
40 Participants Needed
Trial Details
Key Eligibility Criteria
314 Participants Needed
Trial Details
Key Eligibility Criteria
152 Participants Needed
Trial Details
Key Eligibility Criteria
350 Participants Needed
Trial Details
Key Eligibility Criteria
120 Participants Needed
Trial Details
Key Eligibility Criteria
120 Participants Needed
Trial Details
Key Eligibility Criteria
86 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Trial Details
Key Eligibility Criteria
109 Participants Needed
Trial Details
Key Eligibility Criteria
270 Participants Needed
Know someone looking for new options?
Spread the word
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Neuroendocrine Carcinoma trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Neuroendocrine Carcinoma is 12 months.
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
Most recently, we added Belinostat for Neuroendocrine Carcinoma, [212Pb]VMT-Alpha-NET for Neuroendocrine Tumors and 225Ac-ABD147 for Lung Cancer to the Power online platform.